These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2784474)

  • 1. Subendothelial matrix of cultured endothelial cells contains fully processed high molecular weight von Willebrand factor.
    Tannenbaum SH; Rick ME; Shafer B; Gralnick HR
    J Lab Clin Med; 1989 Mar; 113(3):372-8. PubMed ID: 2784474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets.
    de Groot PG; Federici AB; de Boer HC; d'Alessio P; Mannucci PM; Sixma JJ
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3793-7. PubMed ID: 2657729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composition of the von Willebrand factor storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells.
    Ewenstein BM; Warhol MJ; Handin RI; Pober JS
    J Cell Biol; 1987 May; 104(5):1423-33. PubMed ID: 3494734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimer size dependence of von Willebrand factor binding to crosslinked or noncrosslinked fibrin.
    Ribes JA; Francis CW
    Blood; 1990 Apr; 75(7):1460-5. PubMed ID: 2107883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Storage and secretion of von Willebrand factor by endothelial cells.
    Reinders JH; de Groot PG; Sixma JJ; van Mourik JA
    Haemostasis; 1988; 18(4-6):246-61. PubMed ID: 3069641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I von Willebrand disease, subtype 'platelet low': decreased platelet adhesion can be explained by low synthesis of von Willebrand factor in endothelial cells.
    Federici AB; de Groot PG; Moia M; Ijsseldijk MJ; Sixma JJ; Mannucci PM
    Br J Haematol; 1993 Jan; 83(1):88-93. PubMed ID: 8435340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimeric analysis of von Willebrand factor in megakaryocytes.
    Kupinski JM; Miller JL
    Thromb Res; 1985 Jun; 38(6):603-10. PubMed ID: 3875163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin enhances endothelial cell von Willebrand factor content by growth factor dependent mechanisms.
    Tannenbaum SH; Chao ES; Gralnick HR
    Thromb Haemost; 1994 Nov; 72(5):770-6. PubMed ID: 7900084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfation of von Willebrand factor.
    Carew JA; Browning PJ; Lynch DC
    Blood; 1990 Dec; 76(12):2530-9. PubMed ID: 2265247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimeric composition of endothelial cell-derived von Willebrand factor.
    Tsai HM; Nagel RL; Hatcher VB; Sussman II
    Blood; 1989 Jun; 73(8):2074-6. PubMed ID: 2786433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor released from Weibel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively.
    Sporn LA; Marder VJ; Wagner DD
    Blood; 1987 May; 69(5):1531-4. PubMed ID: 3105624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor and the endothelium.
    Wagner DD; Bonfanti R
    Mayo Clin Proc; 1991 Jun; 66(6):621-7. PubMed ID: 2046401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.
    Dent JA; Galbusera M; Ruggeri ZM
    J Clin Invest; 1991 Sep; 88(3):774-82. PubMed ID: 1909351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor in lysates of washed canine platelets.
    Parker MT; Turrentine MA; Johnson GS
    Am J Vet Res; 1991 Jan; 52(1):119-25. PubMed ID: 2021239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced release of von Willebrand factor by human endothelial cells in culture in the presence of phorbol myristate acetate and interleukin 1.
    Giddings JC; Shall L
    Thromb Res; 1987 Aug; 47(3):259-67. PubMed ID: 3307015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells.
    Wagner DD; Fay PJ; Sporn LA; Sinha S; Lawrence SO; Marder VJ
    Proc Natl Acad Sci U S A; 1987 Apr; 84(7):1955-9. PubMed ID: 3494248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen.
    Rand JH; Patel ND; Schwartz E; Zhou SL; Potter BJ
    J Clin Invest; 1991 Jul; 88(1):253-9. PubMed ID: 2056120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.
    Hamilton KK; Fretto LJ; Grierson DS; McKee PA
    J Clin Invest; 1985 Jul; 76(1):261-70. PubMed ID: 3160727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An explanation for minor multimer species in endothelial cell-synthesized von Willebrand factor.
    Lynch DC; Zimmerman TS; Ling EH; Browning PJ
    J Clin Invest; 1986 Jun; 77(6):2048-51. PubMed ID: 3486890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.